Journey Medical Corporation announced that the Company has entered into a credit facility with an affiliate of SWK Holdings Corporation providing for borrowings of up to $20 million. The Credit Facility provides for an initial term loan of $15 million that the Company intends to use to fund general corporate operations and commercial and DFD-29 product development initiatives. The Company also has the option to draw an additional tranche of $5 million under the Credit Facility, subject to the achievement of specified operational and financial metrics, in the twelve months following the date of the credit facility.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 USD | +2.63% | +8.33% | -32.29% |
May. 13 | Transcript : Journey Medical Corporation, Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Journey Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.29% | 78.05M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- DERM Stock
- News Journey Medical Corporation
- Journey Medical Corporation Secures Credit Facility with SWK Holdings for Up to $20 Million